Testing For Hepatitis C Viral Infections : FREQUENTLY ASKED QUESTIONS

Details

• Alternative Title:
  TESTING FOR HEPATITIS C VIRAL INFECTIONS: FAQS
• Corporate Authors:
  Association of Public Health Laboratories ; Centers for Disease Control and Prevention (U.S.)
• Description:
  cdc:59048
  
  In May 2013, the Centers for Disease Control and Prevention released Testing for HCV Infections: An Update of Guidance for Clinicians and Laboratorians. The updated guidelines emphasize identifying persons with current hepatitis C virus (HCV) infections and incorporate recent changes in the availability of certain commercial HCV antibody tests. The new recommended testing sequence includes an initial test with an FDA-approved test for HCV antibodies, followed by an FDA-approved diagnostic nucleic acid test (NAT) intended for the detection of HCV RNA in serum or plasma if the initial HCV antibody test is reactive (Figure 1). This document intends to provide answers to some frequently asked questions regarding the recommended testing sequence and outlines FDA-approved diagnostic HCV RNA tests (Table 1).
  
  aphl_testing_faqs.pdf
  
  
• Subjects:
  Aged Clinical Laboratory Techniques HepaciVirus Hepatitis C Hepatitis C Antibodies Humans Mass Screening RNA, Viral
• Document Type:
  Pamphlet (or booklet)
• Funding:
  Cooperative Agreement # U60HM000803 from CDC
• Pages in Document:
  4 numbered pages
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:dfd4506a37c59d33ee7fd084e43b5e2007533fee71af555662e36a6bef2f81ab
• Download URL:
  https://stacks.cdc.gov/view/cdc/147106/cdc_147106_DS1.pdf
• File Type:
  [PDF - 351.70 KB ]